SCHEMBL14797014

SCHEMBL14797014

Cc1cc(-c2nc3cnc(Oc4cccnc4C)nc3o2)cc(C)c1OCC(=O)O

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
S1PR1 P21453 1/20 0.68
MAPT P10636 4/20 0.37
TP53 P04637 3/20 0.37
HPGD P15428 2/20 0.37
NPSR1 Q6W5P4 2/20 0.37
HSD17B10 Q99714 1/20 0.37
PPARD Q03181 4/20 0.35
FFAR1 O14842 1/20 0.35
LMNA P02545 1/20 0.35
RXFP1 Q9HBX9 1/20 0.35
KDM4E B2RXH2 2/20 0.35
ALDH1A1 P00352 2/20 0.35
MEN1 O00255 1/20 0.35
HTT P42858 1/20 0.35
KMT2A Q03164 1/20 0.35
PTGDR2 Q9Y5Y4 1/20 0.35
CSNK2A2 P19784 1/20 0.34
CSNK2B P67870 1/20 0.34
CSNK2A1 P68400 1/20 0.34
PTPN1 P18031 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14797136 0.90 S1PR1 (0.71) S1PR1MAPTTP53RXFP1CETP
SCHEMBL2225216 0.88 S1PR1 (0.69) S1PR1MAPTTP53PPARDFFAR1
SCHEMBL14797016 0.87 S1PR1 (0.73) S1PR1MAPTKDM4EHTTKMT2A
SCHEMBL14797108 0.86 S1PR1 (0.70) S1PR1MAPTTP53PPARDFFAR1
SCHEMBL2223368 0.86 S1PR1 (0.83) S1PR1MAPTHSD17B10PPARDFFAR1
SCHEMBL14797000 0.86 S1PR1 (0.74) S1PR1MAPTTP53HPGDNPSR1
SCHEMBL14797212 0.85 S1PR1 (0.66) S1PR1MAPTTP53PPARDFFAR1
SCHEMBL14797002 0.85 S1PR1 (0.65) S1PR1PPARDFFAR1PTPN1CETP
SCHEMBL14796982 0.85 S1PR1 (0.67) S1PR1MAPTTP53PPARDFFAR1
SCHEMBL14797105 0.85 S1PR1 (0.65) S1PR1PPARDFFAR1CETP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8846692-B2 Carboxylic acid derivatives having a 2,5-substituted oxazolopyrimidine ring SANOFI (FR) 2014-09-30 US disclosed
US-20130079358-A1 CARBOXYLIC ACID DERIVATIVES HAVING A 2,5-SUBSTITUTED OXAZOLOPYRIMIDINE RING SANOFI (FR) 2013-03-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130079358-A1 CARBOXYLIC ACID DERIVATIVES HAVING A 2,5-SUBSTITUTED OXAZOLOPYRIMIDINE RING OXGR1, EDNRA, EDF1 S1PR1 129/4885MAPT 4394/4885TP53 3613/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.